South and Southeast Asia still shoulder some of the world’s heaviest burdens of cholera, dengue, leptospirosis, meningococcal meningitis and typhoid. Dozens of promising vaccines, therapeutics and diagnostics are already in—or approaching—Phase III trials, yet most will not reach patients unless late-stage financing and delivery barriers are overcome.
This report, supported by Wellcome Trust and in collaboration with Access Partnership, is intended as a convening tool: it maps those barriers, matches them to the right innovative-finance instruments, and identifies where governments, philanthropies, MDBs, manufacturers, and global health agencies must act together to fund the region’s most promising interventions.
